Market Place
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 5Evonik
02 5Gangwal Healthcare
03 1Actylis
04 2Aeon Procare
05 3Alcedo Pharmachem
06 28BASF
07 2Gangwal Chemicals
08 6Ideal Cures Pvt Ltd
09 14Kerry
10 1Kima Chemical
11 1Lonza Capsugel
12 1Sigachi Industries
13 2The Dow Chemical Company
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression
Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Brand : DICOM-DC® SR300
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : GELLETS-P®
Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
LOOKING FOR A SUPPLIER?
